IBDEI1P3 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27090,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,27090,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,27091,0)
 ;;=F16.959^^110^1308^9
 ;;^UTILITY(U,$J,358.3,27091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27091,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,27091,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,27091,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,27092,0)
 ;;=F16.99^^110^1308^17
 ;;^UTILITY(U,$J,358.3,27092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27092,1,3,0)
 ;;=3^Hallucinogen Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,27092,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,27092,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,27093,0)
 ;;=F16.983^^110^1308^16
 ;;^UTILITY(U,$J,358.3,27093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27093,1,3,0)
 ;;=3^Hallucinogen Persisting Perception D/O
 ;;^UTILITY(U,$J,358.3,27093,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,27093,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,27094,0)
 ;;=F16.21^^110^1308^20
 ;;^UTILITY(U,$J,358.3,27094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27094,1,3,0)
 ;;=3^Hallucinogen Use DO,Mod/Sev,In Remiss
 ;;^UTILITY(U,$J,358.3,27094,1,4,0)
 ;;=4^F16.21
 ;;^UTILITY(U,$J,358.3,27094,2)
 ;;=^5003337
 ;;^UTILITY(U,$J,358.3,27095,0)
 ;;=F16.11^^110^1308^18
 ;;^UTILITY(U,$J,358.3,27095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27095,1,3,0)
 ;;=3^Hallucinogen Use DO,Mild,In Remiss
 ;;^UTILITY(U,$J,358.3,27095,1,4,0)
 ;;=4^F16.11
 ;;^UTILITY(U,$J,358.3,27095,2)
 ;;=^268239
 ;;^UTILITY(U,$J,358.3,27096,0)
 ;;=F11.10^^110^1309^25
 ;;^UTILITY(U,$J,358.3,27096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27096,1,3,0)
 ;;=3^Opioid Use DO,Mild,Uncomp
 ;;^UTILITY(U,$J,358.3,27096,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,27096,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,27097,0)
 ;;=F11.129^^110^1309^22
 ;;^UTILITY(U,$J,358.3,27097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27097,1,3,0)
 ;;=3^Opioid Intox w/o Perceptual Dists w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,27097,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,27097,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,27098,0)
 ;;=F11.14^^110^1309^5
 ;;^UTILITY(U,$J,358.3,27098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27098,1,3,0)
 ;;=3^Opioid Induced Depressive D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,27098,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,27098,2)
 ;;=^5003119
 ;;^UTILITY(U,$J,358.3,27099,0)
 ;;=F11.182^^110^1309^11
 ;;^UTILITY(U,$J,358.3,27099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27099,1,3,0)
 ;;=3^Opioid Induced Sleep D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,27099,1,4,0)
 ;;=4^F11.182
 ;;^UTILITY(U,$J,358.3,27099,2)
 ;;=^5003124
 ;;^UTILITY(U,$J,358.3,27100,0)
 ;;=F11.20^^110^1309^28
 ;;^UTILITY(U,$J,358.3,27100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27100,1,3,0)
 ;;=3^Opioid Use DO,Mod/Sev,Uncomp
 ;;^UTILITY(U,$J,358.3,27100,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,27100,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,27101,0)
 ;;=F11.23^^110^1309^26
 ;;^UTILITY(U,$J,358.3,27101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27101,1,3,0)
 ;;=3^Opioid Use DO,Mod/Sev w/ Withdrawal
 ;;^UTILITY(U,$J,358.3,27101,1,4,0)
 ;;=4^F11.23
 ;;^UTILITY(U,$J,358.3,27101,2)
 ;;=^5003133
 ;;^UTILITY(U,$J,358.3,27102,0)
 ;;=F11.24^^110^1309^6
 ;;^UTILITY(U,$J,358.3,27102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27102,1,3,0)
 ;;=3^Opioid Induced Depressive D/O w/ Mod/Sev Use D/O
